Eloxx Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eloxx Pharmaceuticals

14/08/2023 14:32

* Eloxx Pharmaceuticals Inc  ELOX.OQ  reported a quarterly
adjusted loss of $1.96​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of $1.54 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Eloxx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.96​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Eloxx Pharmaceuticals Inc shares had risen by 22.1% this
quarter and gained 161.0% so far this year.
    * The company reported a quarterly loss of $4.34 million.
    * Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $55.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.54          -1.96          Missed
 Mar. 31 2023      -2.55          -2.88          Missed
 Dec. 31 2022      -2.97          -2.92          Beat
 Sep. 30 2022      -4.40          -3.60          Beat